13D/13G Filings - Braeden Lichti

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-03-28
9:47 pm
Purchase
2025-03-26 13D Elevai Labs, Inc. Common Stock
ELAB
Braeden Lichti 3,336,437
52.350%
3,336,437increase
(New Position)
Filing
History
2025-03-28
9:46 pm
Purchase
2024-09-24 13D Elevai Labs, Inc. Common Stock
ELAB
Braeden Lichti 2,733
0.190%
2,733increase
(New Position)
Filing
History
2024-02-21
10:57 am
Purchase
2023-11-13 13D Elevai Labs, Inc. Common Stock
ELAB
Braeden Lichti 2,731
22.070%
2,731increase
(New Position)
Filing
History
2023-07-12
4:26 pm
Purchase
2023-04-18 13G Marizyme, Inc.
MRZM
Braeden Lichti 9,786,874
17.890%
9,786,874increase
(New Position)
Filing
History